Global Minimally Invasive Surgery Market Size, Status and Forecast 2024-2031

Report ID: 955078 | Published Date: Sep 2024 | No. of Page: 107 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story

The rise in geriatric population throughout the globe is contributing greatly to the increasing number of various minimally invasive surgeries (MIS) such as breast, orthopedic, cardiac, gynecological and urological surgeries.This is mainly because, elderly people belong to the high risk patient category for performing conventional open surgeries due to their already compromised health and slow recovery from debilitating conditions. MIS is performed with a tiny incision in the patient’s body that results in faster recovery, minimal stay in the hospital, and minimal pain and trauma to the patient.
These surgeries are performed with the help of various devices that include surgical devices, monitoring and visualization devices, and endoscopy devices.

Market Analysis and Insights: Global Minimally Invasive Surgery Market
The global Minimally Invasive Surgery market size is projected to reach US$ 20970 million by 2027, from US$ 14690 million in 2020, at a CAGR of 5.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Minimally Invasive Surgery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Minimally Invasive Surgery market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Minimally Invasive Surgery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Minimally Invasive Surgery market.

Global Minimally Invasive Surgery Scope and Market Size
Minimally Invasive Surgery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Minimally Invasive Surgery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drugs
Devices
Others

Segment by Application
Hospitals
ASCs

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Medtronic
Abbott Laboratories
Smith & Nephew
Biomet
DePuy Synthes
GE Healthcare
Given Imaging
Intuitive Surgical
NuVasive
Philips Healthcare
Siemens Healthcare
Stryker
Teleflex

Frequently Asked Questions
Minimally Invasive Surgery report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Minimally Invasive Surgery report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Minimally Invasive Surgery report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Life Sciences BPO

Due to the looming patent expiry, healthcare spending cuts, and decline in productive outcome of  ... Read More